Publication:
Zilovertamab Vedotin in Combination With Nemtabrutinib for Patients With Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study

Simple item page
dc.authorwosidVilla, Diego/Cah-8355-2022
dc.authorwosidGlimelius, I/Q-1325-2015
dc.contributor.authorPaszkiewicz-Kozik, Ewa
dc.contributor.authorMoreira, Claudia
dc.contributor.authorTurgut, Mehmet
dc.contributor.authorGarrido, Marcelo
dc.contributor.authorGlimelius, Ingrid
dc.contributor.authorLee, Seung Tae
dc.contributor.authorVilla, Diego
dc.date.accessioned2025-12-11T00:43:24Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Paszkiewicz-Kozik, Ewa] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland; [Moreira, Claudia] Inst Portugues Oncol Porto Francisco Gentil EPE, Porto, Portugal; [Turgut, Mehmet] Mayis Univ, Med Sch, Dept Hematol, Samsun, Turkiye; [Garrido, Marcelo] Univ Mayor, SAGA Clin Trial Ctr, Santiago, Chile; [Glimelius, Ingrid] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Glimelius, Ingrid] Akad Sjukhuset Blod Och Tumorsjukdomar, Uppsala, Sweden; [Lee, Seung Tae] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD USA; [Sawalha, Yazeed] Ohio State Univ, James Canc Hosp, Columbus, OH USA; [Sawalha, Yazeed] Ohio State Univ, Solove Res Inst, Columbus, OH USA; [Ren, Yixin; Ryland, Katherine; Ogbu, Uzor C.] Merck & Co Inc, Rahway, NJ USA; [Villa, Diego] BC Canc, Ctr Lymphoid Canc, Vancouver, BC, Canadaen_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.doi10.1182/blood-2024-205985
dc.identifier.endpage3026en_US
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.scopusqualityQ1
dc.identifier.startpage3025en_US
dc.identifier.urihttps://doi.org/10.1182/blood-2024-205985
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38752
dc.identifier.volume144en_US
dc.identifier.wosWOS:001415684800021
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleZilovertamab Vedotin in Combination With Nemtabrutinib for Patients With Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Studyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu